GRANT PICKERING - 15 Jul 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Executive Officer, Director
Signature
Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
15 Jul 2022
Net transactions value
-$269,187
Form type
4
Filing time
19 Jul 2022, 17:12:02 UTC
Previous filing
28 Jun 2022
Next filing
28 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $202,509 -8,320 -1.2% $24.34 686,136 15 Jul 2022 Direct F1, F2
transaction PCVX Common Stock Sale $66,678 -2,680 -0.39% $24.88 683,456 15 Jul 2022 Direct F1
holding PCVX Common Stock 345,660 15 Jul 2022 By Children's Trusts
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $23.88 to $24.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.